GBS Insider Trading

Insider Ownership Percentage: 0.27%
Insider Buying (Last 12 Months): $34,723.70
Insider Selling (Last 12 Months): $878,000.00

GBS Insider Trading History Chart

This chart shows the insider buying and selling history at GBS by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

GBS Share Price & Price History

Current Price: $0.47
Price Change: Price Decrease of -0.0002 (-0.04%)
As of 10/26/2022 09:56 PM ET

This chart shows the closing price history over time for GBS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Q4 Earnings Announcements…
That’s right… Q4 earnings announcements are coming… And these five microcap stocks appear to be in an excellent position to see a surge in share price.
>>> Click here to see all 5 stocks

GBS Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/22/2022Spiro Kevin SakirisCFOBuy5,000$0.65$3,250.0050,228View SEC Filing Icon  
6/17/2022Spiro Kevin SakirisInsiderBuy15,970$0.61$9,741.7045,228View SEC Filing Icon  
2/16/2022Science Biosensor Diagnos LifeMajor ShareholderSell100,000$0.63$63,000.00View SEC Filing Icon  
2/14/2022Science Biosensor Diagnos LifeMajor ShareholderSell100,000$0.70$70,000.00View SEC Filing Icon  
2/10/2022Science Biosensor Diagnos LifeMajor ShareholderSell100,000$0.84$84,000.00View SEC Filing Icon  
2/8/2022Science Biosensor Diagnos LifeMajor ShareholderSell100,000$0.89$89,000.00View SEC Filing Icon  
2/2/2022Science Biosensor Diagnos LifeMajor ShareholderSell100,000$0.92$92,000.00View SEC Filing Icon  
1/31/2022Science Biosensor Diagnos LifeMajor ShareholderSell100,000$0.90$90,000.00View SEC Filing Icon  
1/28/2022Science Biosensor Diagnos LifeMajor ShareholderSell100,000$0.92$92,000.00View SEC Filing Icon  
12/17/2021Science Biosensor Diagnos LifeMajor ShareholderSell200,000$1.49$298,000.00View SEC Filing Icon  
12/16/2021Tom ParmakellisDirectorBuy2,800$1.69$4,732.00View SEC Filing Icon  
12/6/2021Spiro Kevin SakirisInsiderBuy10,000$1.70$17,000.00View SEC Filing Icon  
11/29/2021Science Biosensor Diagnos LifeMajor ShareholderSell100,000$1.69$169,000.00View SEC Filing Icon  
11/24/2021Science Biosensor Diagnos LifeMajor ShareholderSell100,000$1.64$164,000.00View SEC Filing Icon  
11/9/2021Science Biosensor Diagnos LifeMajor ShareholderSell300,000$2.02$606,000.00View SEC Filing Icon  
10/21/2021Science Biosensor Diagnos LifeMajor ShareholderSell248,416$2.26$561,420.16View SEC Filing Icon  
10/19/2021Science Biosensor Diagnos LifeMajor ShareholderSell16,326$2.25$36,733.50View SEC Filing Icon  
10/14/2021Science Biosensor Diagnos LifeMajor ShareholderSell100,726$2.18$219,582.68View SEC Filing Icon  
10/12/2021Science Biosensor Diagnos LifeMajor ShareholderSell100,000$2.13$213,000.00View SEC Filing Icon  
10/8/2021Science Biosensor Diagnos LifeMajor ShareholderSell200,000$2.30$460,000.00View SEC Filing Icon  
9/28/2021Science Biosensor Diagnos LifeMajor ShareholderSell200,000$2.48$496,000.00View SEC Filing Icon  
9/28/2021Tom ParmakellisDirectorBuy1,000$2.40$2,400.00View SEC Filing Icon  
9/24/2021Science Biosensor Diagnos LifeMajor ShareholderSell200,000$2.66$532,000.00View SEC Filing Icon  
9/22/2021Science Biosensor Diagnos LifeMajor ShareholderSell100,000$2.80$280,000.00View SEC Filing Icon  
9/20/2021Science Biosensor Diagnos LifeMajor ShareholderSell100,000$2.90$290,000.00View SEC Filing Icon  
9/17/2021Science Biosensor Diagnos LifeMajor ShareholderSell45,152$3.29$148,550.08View SEC Filing Icon  
6/21/2021Tom ParmakellisDirectorBuy1,000$4.44$4,440.001,000View SEC Filing Icon  
2/24/2021Christopher TowersDirectorBuy800$6.84$5,472.00800View SEC Filing Icon  
See Full Table
5 Stocks in the News…
Things like news releases or earnings announcements can be important triggers to look for… And we found 5 stocks that appear to be in an excellent position to deliver high-probability trading opportunities in the days and weeks ahead.

Click Here to Get ALL 5 Stocks.

SEC Filings (Institutional Ownership Changes) for GBS (NYSE:GBS)

2.79% of GBS stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at GBS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

GBS Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/13/2022Renaissance Technologies LLC111,900$74K0.0%+65.8%0.752%Search for SEC Filing on Google Icon
5/17/2022Virtu Financial LLC89,394$70K0.0%N/A0.601%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.42,800$33K0.0%N/A0.288%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC67,500$53K0.0%N/A0.454%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.21,812$55K0.0%+4,119.0%0.147%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC24,897$98K0.0%N/A0.201%Search for SEC Filing on Google Icon
8/17/2021Bridgeway Capital Management LLC118,000$0.47M0.0%+555.6%0.953%Search for SEC Filing on Google Icon
8/13/2021Anson Funds Management LP571,401$2.25M0.2%N/A4.615%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC10,938$43K0.0%N/A0.088%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.18,854$74K0.0%N/A0.152%Search for SEC Filing on Google Icon
8/6/2021WealthShield Partners LLC49,147$0.19M0.0%N/A0.397%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC27,939$0.16M0.0%N/A0.226%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC27,939$0.16M0.0%N/A0.235%Search for SEC Filing on Google Icon
2/17/2021Jane Street Group LLC16,182$0.12M0.0%N/A0.137%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
GBS logo
GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Read More on GBS

Today's Range

Now: $0.47
Low: $0.45
High: $0.49

50 Day Range

MA: $0.44
Low: $0.34
High: $0.55

52 Week Range

Now: $0.47
Low: $0.36
High: $2.89


11,000 shs

Average Volume

955,325 shs

Market Capitalization

$7.05 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of GBS?

GBS's top insider investors include:
  1. Spiro Kevin Sakiris (CFO)
  2. Spiro Kevin Sakiris (Insider)
  3. Tom Parmakellis (Director)
  4. Christopher Towers (Director)
  5. Science Biosensor Diagnos Life (Major Shareholder)
Learn More about top insider investors at GBS.